Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception.

about

Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception.

Item

http://www.wikidata.org/entity/Q47147106

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Synthesis and pharmacological ...... long-lasting antinociception.

@en

Synthesis and pharmacological ...... long-lasting antinociception.

@nl

type

Item

label

Synthesis and pharmacological ...... long-lasting antinociception.

@en

Synthesis and pharmacological ...... long-lasting antinociception.

@nl

prefLabel

Synthesis and pharmacological ...... long-lasting antinociception.

@en

Synthesis and pharmacological ...... long-lasting antinociception.

@nl

P1476

Synthesis and pharmacological ...... long-lasting antinociception.

@en

P2093

Amanda Hunkele

http://www.w3.org/2001/XMLSchema#string

András Váradi

http://www.w3.org/2001/XMLSchema#string

Balázs Komjáti

http://www.w3.org/2001/XMLSchema#string

Gavril W Pasternak

http://www.w3.org/2001/XMLSchema#string

Levente Szőcs

http://www.w3.org/2001/XMLSchema#string

Susruta Majumdar

http://www.w3.org/2001/XMLSchema#string

Sándor Hosztafi

http://www.w3.org/2001/XMLSchema#string

Valerie Le Rouzic

http://www.w3.org/2001/XMLSchema#string

Ákos Urai

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine

Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.

Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.

Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.

Determination of receptors that mediate opiate side effects in the mouse.

Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity.

Opioid pharmacology.

Preclinical disposition (in vitro) of novel μ-opioid receptor selective antagonists.

Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.

Characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives as novel leads to development of mu opioid receptor selective antagonists.

P304

152-157

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C6MD00450D

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28603600

http://www.w3.org/2001/XMLSchema#string

P932

5464418

http://www.w3.org/2001/XMLSchema#string